SLEEP MEDICINE

Pear Therapeutics’ Somryst intervention provides tailored neurobehavioral interventions intended to improve the symptoms of insomnia, via cognitive behavioral therapy and algorithm-driven sleep restriction.
The director of the Sleep Disorders Center and vice chair of the department of neurology at the UCLA David Geffen School of Medicine detailed the comorbidities related to narcolepsy.  

SAP Partner Banner

About NeurologyLive's Sleep Medicine Clinical Focus page:

Content found within NeurologyLive's Sleep Medicine Clinical Focus page offers the latest and most valuable information on emerging therapies for sleep disturbances and disorders. Articles include relevant updates from the floor of the most notable neurology conferences and annual meetings, as well as video interviews with the leading experts in neurology, especially those specializing in the treatment of narcolepsy and obstructive sleep apnea.
 
A lack of sleep has proven to be damaging to physical, mental, and emotional health, and the content offered on this page, which includes breaking news coverage of approvals from the U.S. Food and Drug Administration (FDA), key takeaways from recent clinical trials of new and emerging therapies, and notifications of updates to clinical guidelines, is intended to dramatically improve patient care.